Expand MANE Menu
MANE MENU

MANE Latest Press Releases

-- July 17, 2026 --

Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study '302' in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy Business Wire 7:30 AM

-- July 15, 2026 --

Veradermics' Oral VDPHL01 Delivers Positive Study '207' Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study '306' Readout Business Wire 7:00 AM

-- July 14, 2026 --

Veradermics to Hold Conference Call to Discuss Study '207' Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss Business Wire 6:54 PM

-- June 2, 2026 --

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors Globe Newswire 8:30 AM

-- May 28, 2026 --

Veradermics to Present at Upcoming June Investor Conferences Business Wire 4:30 PM

-- May 27, 2026 --

Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 '302' Study of VDPHL01 at the 2026 World Congress for Hair Research Business Wire 7:30 AM

-- May 14, 2026 --

Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium Business Wire 7:30 AM

-- May 12, 2026 --

Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress Business Wire 7:30 AM

-- April 29, 2026 --

Veradermics Announces Pricing of Upsized Public Offering and Private Placement Business Wire 10:32 PM

-- April 27, 2026 --

Veradermics Announces Launch of Public Offering Business Wire 5:26 PM
Veradermics' Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 '302' Clinical Trial in Male Pattern Hair Loss Business Wire 7:00 AM

-- April 26, 2026 --

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 '302' Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss Business Wire 4:00 PM

-- March 30, 2026 --

Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates Business Wire 7:30 AM

-- March 18, 2026 --

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting Business Wire 7:00 AM
Market Data Delayed 15 Minutes